## **Core Concept**
Alzheimer's disease is a neurodegenerative disorder characterized by cognitive decline and memory loss. Neurotransmitters play a crucial role in transmitting signals in the brain, and their imbalance or deficiency can lead to various neurological disorders. The key neurotransmitters involved in Alzheimer's disease are those that regulate memory, learning, and cognitive functions.

## **Why the Correct Answer is Right**
The correct answer involves neurotransmitters that are known to be decreased in Alzheimer's disease. **Acetylcholine (ACh)** and **glutamate** are the primary neurotransmitters implicated in the pathophysiology of Alzheimer's disease. Acetylcholine is crucial for memory formation and learning, and its levels are significantly reduced in Alzheimer's patients. This decrease is associated with the degeneration of cholinergic neurons in the basal forebrain. Glutamate, the most abundant excitatory neurotransmitter in the brain, also plays a role in cognitive functions and is affected in Alzheimer's disease.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option might include neurotransmitters not primarily associated with decreased levels in Alzheimer's disease.
- **Option B:** Similarly, this could include neurotransmitters that are not directly implicated in the cognitive decline seen in Alzheimer's.
- **Option D:** This option might list neurotransmitters that are actually increased or not directly related to the primary pathophysiology of Alzheimer's disease.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **donepezil**, a **cholinesterase inhibitor**, is used in the treatment of Alzheimer's disease to increase acetylcholine levels in the brain, thereby improving cognitive function. This highlights the importance of acetylcholine in the management of Alzheimer's.

## **Correct Answer:** .